The global gelatin market is experiencing significant growth, driven by several key trends and opportunities. The growing consumer demand for transparency and natural ingredients has significantly increased the use of gelatin in food and beverage products. The gelatin market is experiencing a moderate to high level of mergers and acquisitions (M&A) activity, indicating a strategic consolidation trend among key industry players, driven by market expansion, product portfolio diversification, and technological advancements. These strategic mergers and acquisitions are reshaping the gelatin market, enabling companies to enhance their capabilities, expand their market reach, and meet the evolving demands of consumers .
For instance, in August 2024, Zydus Lifesciences acquired a 50% stake in Sterling Biotech from Perfect Day Inc., forming a 50:50 joint venture. This collaboration aims to transition Sterling Biotech's focus towards producing fermented, animal-free proteins, catering to the growing demand for sustainable and ethically sourced nutrition. Gelatin, a natural protein derived from collagen, is increasingly vital across food & beverage, pharmaceutical, and cosmetic industries due to its multifunctional properties such as gelling, stabilizing, and emulsifying, making it indispensable in a wide array of applications ranging from gummies and desserts to capsule production and beauty supplements. The escalating demand for gelatin is primarily fueled by a surge in health-conscious consumer behavior, rising preference for clean-label and protein-rich foods, and the expanding use of gelatin in pharmaceutical formulations, including hard and soft gel capsules. According to the research report "Global Gelatin Market Outlook, 2031," published by Bonafide Research, the Global Gelatin market was valued at USD 3.91 Billion in 2025, and expected to reach a market size of more than USD 5.72 Billion by 2031 with the CAGR of 6.73% from 2026-2031. Key players, such as Tessenderlo Group and Gelita AG, rely heavily on research and development to support innovation and market position .
In May 2022, Rousselot launched Quali-Pure HGP 2000, an endotoxin-controlled gelatin for vaccines and wound healing. In 2021, Rousselot extended its range of purified, pharmaceutical-grade, modified gelatins with X-Pure GelDAT. It grows because of its wide range of uses in food and beverages, medicine, and cosmetics. Collagen-derived protein gelatin has applications as a thickening, stabilizing, and gelling agent and finds an application in pharmaceutical purposes for capsules and tablets .
Its application in cosmetics is realized owing to its film-forming and moisturizing properties. Technological advancements in the methods of production and the development of alternative gelatins make the market grow because of dietary and ethical purposes. Manufacturers are responding by offering specialty gelatin types, such as bovine- and fish-based gelatin, to cater to religious and dietary preferences. Companies are also improving transparency through certifications and traceability tools, addressing growing consumer concerns around ingredient origins and sustainability. gelatin production is highly dependent on the availability and pricing of animal by-products from the meat and leather industries, which can be affected by factors such as livestock disease outbreaks, supply chain disruptions, or changing meat consumption trends .
These issues contribute to raw material cost volatility and pose challenges to maintaining stable production. The surge of plant-based gelatin alternatives in the global gelatin market is rooted in a variety of inter-locking trends, each reinforcing the other and collectively accelerating the source-shift away from traditional animal-derived gelatin. Changing consumer lifestyles & ethics play a pivotal role: an increasing number of consumers are embracing vegetarian or vegan diets or at least flexitarian ones, and they are more conscious about animal welfare, environmental sustainability and ingredient transparency. Traditional gelatin derived typically from bovine or porcine collagen can face challenges when it comes to halal, kosher, vegetarian- or vegan-compliant applications. Plant-based alternatives such as agar-agar, pectin or carrageenan are more inherently compatible with a broader range of dietary restrictions and religious requirements, thereby opening up new application growth in food & beverage, pharmaceuticals and personal care .
Clean-label, health & wellness trends are boosting adoption: Manufacturers and consumers alike increasingly priorities natural, minimal-processing and additive-light ingredient lists. Plant-based gelling agents align with this agenda, enabling formulations that can tout vegetarian status, allergen-management and sustainable sourcing. As research indicates, increasing awareness of ingredient origin and a shift toward plant-based options accelerate growth of gelatin substitutes. Historically one barrier to plant-based substitutes was that they did not exactly match the gelling strength, melt behaviour or mouthfeel of animal-gelatin .
But with advances in extraction, processing, hydrocolloid science and formulation, plant-based gelling systems are becoming more sophisticated, helping producers adopt them in wider applications with fewer trade-offs. The dominance of the Type B gelatin manufacturing route in the global gelatin market is the result of several interlocking advantages supply-chain, cost, functional performance and dietary adaptability which together render the alkaline-based Type B process far more favorable for large-scale commercial deployment than its acid-pretreated counterpart. Type B gelatin is typically derived from bovine hides or bones via an alkaline hydrolysis process, which leverages widely available by-products of meat and leather industries. The use of abundant raw materials means producers can scale capacity, keep costs relatively low, and manage supply more reliably. The manufacturing economics of Type B are favourable alkaline treatment results in a lower isoelectric point and a molecular profile with higher gel strength under certain conditions .
These features make Type B especially suitable for high-load pharmaceutical excipients, certain food uses where strong gelling or stabilizing is needed, and where more robust chemical conditions are present. Indeed, one source states that Type B gelatin is preferred for sustained-release and high-drug-load matrices thanks to its stability and binding characteristics. Type B gelatin occupies a strategic position in markets with dietary or regulatory constraints. Since it is derived predominantly from bovine sources via alkaline treatment, this route can more easily accommodate certifications when managed carefully, compared with some porcine-acid derived Type routes .
Although the alkaline pretreatment takes more time and rigor compared to the acid pretreatment of Type A, the converted collagen matrix enables a more uniform molecular weight distribution and strong gel‐forming network with good thermal and pH stability. Gelatin is a natural hydrocolloid obtained from collagen, and its ability to form clear, thermo-reversible gels gives it a technical edge over most other gelling substances. In the food and beverage industry by far the largest consumer of gelatin its gelling function plays a crucial role in determining the texture, stability, and sensory quality of products such as gummies, marshmallows, jellies, desserts, yogurt, and meat products. The gelling property allows these foods to achieve the ideal mouthfeel and structural integrity that consumers expect, while its reversibility provides the signature melt-in-mouth sensation highly valued in confectionery and dessert segments. From a technical standpoint, gelatin’s gelation mechanism where solubilized collagen molecules form a three-dimensional network during cooling produces consistent, elastic, and transparent gels .
This process can be easily customized by adjusting parameters like concentration, pH, and bloom strength, allowing manufacturers to fine-tune product texture and stability for diverse formulations. Compared to other hydrocolloids like agar, carrageenan, or pectin, gelatin offers a more neutral taste and excellent foaming and emulsifying capabilities, making it more multifunctional and economical for large-scale industrial use. The growing global demand for processed and convenience foods further amplifies the need for gelatin as a gelling agent. As urbanization and rising disposable incomes boost the consumption of ready-to-eat meals, confectioneries, and dairy desserts, the reliance on gelatin to provide structure and consistency becomes critical. The healthcare and pharmaceuticals sector has emerged as the fastest-growing application segment in the global gelatin market due to its unique convergence of biomedical functionality, biocompatibility, and expanding therapeutic applications .
Gelatin, derived primarily from collagen, offers key physicochemical properties such as gelling, film-forming, and binding capabilities that make it an ideal excipient and encapsulation material in modern medicine. Its natural origin, safety profile, and digestibility position it as a preferred material for medical formulations and drug delivery systems. A primary driver behind this growth is gelatin’s dominant role in capsule manufacturing, both hard and soft. Gelatin capsules are widely used because they provide excellent protection for sensitive ingredients, ensure easy swallowing, and allow precise dosing .
The material’s ability to dissolve rapidly at body temperature ensures effective bioavailability of encapsulated drugs. As the nutraceutical and dietary supplement industries expand, driven by consumers’ pursuit of immunity, joint health, and wellness, the demand for gelatin capsules continues to rise sharply. Gelatin hydrogels and sponges are extensively used in wound dressings, hemostatic agents, and surgical applications where controlled moisture retention, tissue adhesion, and bio resorption are essential. The increasing number of surgical procedures and trauma cases worldwide, coupled with growing investments in regenerative medicine, has created a strong demand for gelatin-based biomaterials.